Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRISMA-2: Risperidone ISM PK Study
NCT02086786Phase 2Completed
- Sponsor
- Laboratorios Farmacéuticos ROVI
- Start
- Mar 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of risperidone in schizophrenia, sponsored by Laboratorios Farmacéuticos ROVI. Started Mar 2014; status: completed.
02
Drugs
risperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02086786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02086786.